Timetech Formulations - "Sustained Success"

Hyderabad based Timetech Formulations Ltd., a forerunner in new drug delivery pellets technology and various timed release formulations, produces a wide range of products that include antibiotics, anti-allergens, anti-ulcerates and cardio-protective drugs.

G.N. Raju, Managing Director, said, "Timetech was formed in 1996, for the concept of the Novel Drug Delivery System. It has been a family owned business since the beginning". The formulations of the Company are inclined towards making innovative drugs. The company has a well-equipped state-of-the art manufacturing facility at Kukatpally on the outskirts of the city. Timetech, is all set to deliver fully integrated drug delivery system solutions, including formulation and development studies, product registration and manufacturing.

There was a need and a demand for optimizing therapy with established drugs. The Novel Drug Delivery System (NDDS) wit hits efficacious solutions is providing the panacea for qualitative medication. Through better understanding of pharmacokinetics and low toxicity, NDDS has now come to be recognised as the answer for safe and effective delivery of drugs. Raju said, "The NDDS renders the patients increased efficacy, simplicity, safety compliance and comfort. For the healthcare providers, the system improves the cost effectiveness of drugs and treatment. When compared with multi-dosing preparations, the cost effectiveness would be 20 to 30 per cent".

The NDDS is highly beneficial for patients: it helps in reduction of adverse effects; it is also capable of preventing high, localized concentration of a drug, thus minimizing gastric irritation; it enhances patient compliance in reducing the frequency of dosage.

By maintaining the blood levels in the therapeutic range from longer duration, the NDDS does the effective management of the disease condition. By avoiding the night time dosage, the NDDS helps the patients, which otherwise could cause disturbance to them.

Timetech is manufacturing and marketing various pharmaceutical formulations like antibiotics, anti-allergens, anti-ulcerates, cardio-protective drugs, NSAIDS, nutritional and anti-bacterial.

The company has diversified its formulation-making activity to neuro, psychiatry and diabetic segments by developing molecules in SR formulations. The company's timed-release pellets and formulations are exported to U.S.S.R., South African countries and some parts of Europe. It will continue its efforts to develop newer molecules under the NDDS, and it aims at being the best among equals.

They have their own R&D setup for drug discovery and an able marketing department for selling their products and recently have also started exporting pharmaceuticals.

Timetech has acquired an 80,000 sq. ft. area in the Bollaram region of Hyderabad. At this new facility, formulation development will be of highest priority. They plan on starting this new facility in 2009, which will comply with the latest regulatory norms. Their expected turnover is slated to increase from Rs. 3 crores to Rs. 10 crores. Efforts are on to combine all the different facilities under the Timetech banner.

What does the future hold fro Timetech? Raju explained, "Though Timetech is still independent in its operations, we are on the lookout for partnerships for research and development. Since we are experts in the line of NDDS, we plan not to deviate from this area of expertise. Instead we strive to further evolve with the concept of NDDS".

The formulations they produce are sold directly to their customers. They undertake contract manufacturing from pharma companies and also make their own products which are sold in the ethical market through hospitals and doctors' prescriptions.

The Company owes its grand success to it's well experienced, qualified, and committed technocrats; good teamwork with conscious and continuous effort to upgrade knowledge and technology; and quality consciousness of individuals and stringent methods of quality checks, at different levels.

Timetech believes Pharmaceuticals is an evergreen industry. They strive to maintain their level of quality and regulatory standards. Market monopoly seems to be their ambition by way of producing unique pharmaceuticals. And offering lower cost options to patients has always been the dictum. So far, it has been smooth sailing for the Company, largely due to its strong hold in the market.

Raju proudly said, "Timetech has reached a stage where it is ready to take up any challenges in the Novel Drug Delivery System".